CLINICAL_TRIALS
trial_result
· 2012-05-24
Clinical Trial Update: Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients [Phase 3]
Summary
Phase 3 study of icotinib in non-small cell lung cancer completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-05-24